imipramine has been researched along with Drop Attack in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gouffault, J | 1 |
| Van den Driessche, J | 1 |
| Pony, JC | 1 |
| Courgeon, P | 1 |
| Thomas, R | 1 |
| Saraf, KR | 1 |
| Klein, DF | 1 |
| Gittelman-Klein, R | 1 |
| Groff, S | 1 |
2 trials available for imipramine and Drop Attack
| Article | Year |
|---|---|
[Conduction disorders induced by piperazine; clinical and experimental study].
Topics: Adult; Antipsychotic Agents; Bradycardia; Bundle-Branch Block; Cerebral Hemorrhage; Clinical Trials | 1973 |
Imipramine side effects in children.
Topics: Adolescent; Anorexia Nervosa; Blood Pressure; Child; Constipation; Death, Sudden; Depression, Chemic | 1974 |